
|Videos|May 25, 2022
Urology Times 50 Innovations Series: Dr. Jennifer Linehan on HIFU for prostate cancer
Author(s)Urology Times staff
"In trying to localize and focalize the treatment on just the lesion of prostate cancer, HIFU was incredibly powerful in the sense that it really allowed you to do that with great precision," said Jennifer Linehan, MD.
Advertisement
As part of the Urology Times' 50th Anniversary Innovation Celebration, Jennifer Linehan, MD, discusses how high-intensity focused ultrasound (HIFU) revolutionized the way urologists treat localized prostate cancer. This techology, she emphasizes, creates another safe and effective minimally-invasive therapy for this population of patients. Linehan is an associate professor of urology and urologic oncology at the John Wayne Cancer Institute in Santa Monica, California.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Unmet needs and emerging solutions in MRI-guided prostate cancer care
2
HHS requests testosterone therapy label updates, citing new safety data
3
Microbial dysbiosis may predict response to CBM588 in mRCC
4
Eugene Pietzak, MD, on pembrolizumab plus BCG for BCG-naïve “very high risk” T1 NMIBC
5

















































